FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RESENCATINIB
异名/同义词6-(((2R)-2-HYDROXY-2-METHYL-3-BUTYN-1-YL)OXY)-4-(6-(6-((6-METHOXY-3-PYRIDINYL)METHYL)-3,6-DIAZABICYCLO(3.1.1)HEPT-3-YL)-3-PYRIDINYL)PYRAZOLO(1,5-A)PYRIDINE-3-CARBONITRILE
6-(((2R)-2-HYDROXY-2-METHYLBUT-3-YN-1-YL)OXY)-4-(6-(6- ((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- DIAZABICYCLO(3.1.1)HEPTAN-3-YL)PYRIDIN-3- YL)PYRAZOLO(1,5-A)PYRIDINE-3-CARBONITRILE
PYRAZOLO(1,5-A)PYRIDINE-3-CARBONITRILE, 6-(((2R)-2-HYDROXY-2-METHYL-3-BUTYN-1-YL)OXY)-4-(6-(6-((6-METHOXY-3-PYRIDINYL)METHYL)-3,6-DIAZABICYCLO(3.1.1)HEPT-3-YL)-3-PYRIDINYL)-
RESENCATINIB
RESENCATINIB [INN]
CAS登记号2546117-79-5
物质唯一标识(Unique Ingredient Identifier)VW69FG2AYB
分子式C30H29N7O3
国际化合物标识(International Chemical Identifier,InChI)WNPSOODWDSNATA-DPHZAUTASA-N
SMILESC(#N)c1c2c(cc(OC[C@](C#C)(C)O)cn2nc1)-c3ccc(nc3)N4CC5N(Cc6ccc(OC)nc6)C(C4)C5
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System